“showed a trend”

Higher serum K + significantly correlated with emotional well-being (r = 0.70, p = 0.01) and showed a trend for better general health (r = 0.54, p = 0.09) and less fatigue (r = 0.56, p = 0.07).

9.3 months, HR =0.70; 95% CI, 0.51–0.96; P=0.02) symptom scales and showed a trend in delaying the GHS/QoL (5.0 vs. 4.8 months, HR =0.79; 95% CI, 0.58–1.07; P=0.09).

Atf4 overexpression increased Atf4 mRNA levels compared to control-transfected cells ( Figure 4K ) and showed a trend towards increasing survival of detached non-metastatic cells ( Figure 4L , 8%, P =0.09).

Here, male DG piglets showed significantly lower MR mRNA expression ( p < 0.01) and male DA piglets showed a trend towards lower MR mRNA expression ( p = 0.09) compared to male C piglets.

3 B), which such rate at 24 weeks showed a trend to be higher in the R10Z group (difference in proportion: 11.2%, p = 0.09).

The univariate survival analysis showed a trend towards longer survival in patients diagnosed with PGCC at the initial PCa diagnosis (58 ± 7 vs 25 ± 6 months, p = 0.09).

Given that the primary analysis showed a trend toward improved sleep quality, assessed by the mean difference in PSQI scores, with cannabis oil compared to placebo ( p = 0.09), we performed post hoc exploratory analyses to further investigate this finding.

In the adult G127X mice the AISs also showed a trend to become thinner distally (2.1%, P = 0.0904) and moved significantly closer to the soma, in fact, this was much more pronounced (37.1% closer, P < 0.0001).

Given that the PSD95 area in +/GS dSPNs showed a trend towards decrease (+/RC, 94% of control, +/GS , 83% of control, one-way ANOVA p=0.0904, post-hoc +/+ vs +/GS p=0.075) ( Figure 2—figure supplement 1A,B ), we evaluated the percentage of the GluA1-PSD95 overlap relative to the total PSD95 area across genotypes. 32% of total PSD95 area contained GluA1 in +/RC dSPNs, compared to 23% in +/+ neurons, and 26% in +/GS neurons (one-way ANOVA p=0.0015, post hoc tests as noted) ( Figure 2H ).

Embryonic myr-AKT-AAV1 treatment also showed a trend for amelioration of invasion volume under a setting of 20% FBS w/o HI albeit without a statistical significance ( P = 0.0906) (Supplementary Fig. 9H–K ), suggesting a partial efficacy of AKT1 transduction to alleviate the defects by COX-2 insufficiency and also its limitation to recover other unknown defects with FBS.

Adhesion formation on the uterus was also evaluated, and AMY109 showed a trend toward reducing the uterine adhesion score ( P = 0.0907; Fig. 6 A and B).

In the next modeling step, individuals with trauma exposure showed a trend for greater within-SN connectivity ( b = 0.0175, SE = 0.0103, 95% CI [−0.0173, 0.0229], p = 0.0909), with an effect size of η p 2 = 0.03.

GBR treatment from P42-51 showed a trend for reduced aggressive behavior ( t (37) = 1.763, p = 0.0909).

SNP treatment showed a trend to decrease ( P = 0.091) the protein synthesis rate of myoblasts ( Fig. 8 L).

In contrast, SG showed a trend toward increased gastrin secretion without reaching statistical significance ( p = 0.091), and neither procedure caused hypergastrinemia.

Forced vital capacity (% predicted) (FVC %) showed a trend towards a greater decline in the UIP group, ( p = 0.091).

Fecal propionic and butyric acid levels showed a trend towards lower concentrations in people with T2D compared either to NonDM ( p = 0.091) and preDM ( p = 0.090), respectively; however, these differences did not reach statistical significance.

Comparison of clinical outcomes between patients with KMT2A -PTD <0.1% (group 1), ≥0.1% but <1% (group 2), and ≥1% (group 3) before HID HSCT Patients in group 3 had a higher 2-year cumulative incidence of relapse after HID HSCT (36.4%, 95% confidence interval [CI]: 6.3%–66.5%) compared with those in group 1 (7.7%, 95% CI: 0.0%–16.2%) ( P = .016), and showed a trend of higher 2-year cumulative incidence of relapse compared with those in group 2 (7.1%, 95% CI: 0.0%–21.1%) ( P = .091) ( Fig. 3 A ).

Analysis of the primary endpoint 6MWD with O 2 administration showed a trend in improvement for all patients receiving LTOT (all patients: 35 ± 81.6 m improvement by LTOT; p = 0.091) and for the intervention vs. control group (O 2 group 47.8 ± 88.9 m vs. control − 11.5 ± 21.4 m).

11.6%, p = 0.049) and bleeding events showed a trend toward difference in favor of the Sb‐VCD group (5.8% vs. 14.5%, p = 0.091), not meeting the pre‐specified threshold for statistical significance but being the most common types of vascular complication observed (Table 2 ).

Transgenic rats showed a trend toward fewer correct choices than Wt rats ( P = 0.091, repeated measures ANOVA; Figure 4 E).

In multivariate linear regression models, only age remained significant (β=.268, p=0.004) for PWV while torsion showed a trend for significance (β=.178, p=0.091).

Relationship between the BMI and NAT BP ND The BMI and BP ND showed a trend towards parabolic relation forming a U-shaped graph in the hypothalamus ( Figure 6 ; r 2 = 0.042, p = 0.091).

As shown in Table 6 , the severity of maternal asthma exacerbation showed a trend toward an increased risk of fetal complications (β = 0.679; OR 1.97; 95%CI 0.90-4.34; p=0.091), while systemic corticosteroid therapy demonstrated a protective trend (β = -1.602; OR 0.20; 95%CI 0.03-1.20; p=0.079).

Moreover, higher protein carbonylation levels showed a trend toward reduced survival ( p = 0.091).